Abstract
Enabling, empowering and educating a woman to make the right choice between breast-conserving surgery and mastectomy are aligned with the fundamental principle of bioethics, that is, respect for patient autonomy. A clear understanding of the contemporary ethical and social issues related to genetic testing for breast cancer is necessary to develop a practical approach for counselling, testing and treating patients with genetic disposition to breast cancer. Ethnic inequities, disparities, opportunity and timeliness to treatment and its prognostic significance on breast cancer mortality have been studied in several populations worldwide. While the underutilisation of screening mammography can be attributed to socioeconomic and cultural and geographic barriers, ethical principles must be taken into account. The debate regarding no intervention for low-grade ductal carcinoma in situ and the issue of overdiagnosis are further ethical issues that raise concerns in the informed decision process and the ethical concepts of no harm and autonomy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kim C, Liang L, Wright FC, Hong NJL, Groot G, Helyer L, Meiers P, Quan ML, Urquhart R, Warburton R, Gagliardi AR. Interventions are needed to support patient-provider decision-making for DCIS: a scoping review. Breast Cancer Res Treat. 2018;168(3):579–92. https://doi.org/10.1007/s10549-017-4613-x.
Kennedy Report. Review of the response of Heart of England NHS Foundation Trust to concerns about Mr I Paterson’s Surgical Practice: lessons to be learned and recommendations.
Beauchamp TL, Childress JF. Respect for autonomy from the book principle of biomedical ethics. 7th edition. New York, Oxford: Oxford University press.
Mendick N, Young B, Holcombe C, Salmon P. The ethics of responsibility and ownership in decision-making about treatment for breast cancer. Triangulation of consultation with patient and surgeon’s perspective. Soc Sci Med. 2010;70(12):1904–11.
Caldon L, Walters SJ, Reed MW. Changing trends in decision-making preferences of women with early breast cancer. The. Br J Surg. 2008;95(3):312–8.
Dyers C. Woman who rejected breast cancer diagnosis may undergo surgery without her consent. BMJ. 2017;j5358:359.
Bernhardt BA, et al. Educating patients about cystic fibrosis carrier screening in a primary care setting. Archives of family medicine five; 1996. p. 336–40.
McKenzie C. Relational autonomy, normative authority and perfectionism. J Soc Philos. 2008;39:512–33.
Bundred NJ, Thomas J, Dixon JMJ. Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after Paterson. Breast Cancer Res Treat. 2017;165:473.
Pusic AL, Matros E, Fine N, Buchel E, Gordillo GM, Hamill JB, Kim HM, Qi J, Albornoz C, Klassen AF, Wilkins EG. Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study. J Clin Oncol. 2017;35(22):2499–506.
Association of Breast Surgery at BASO. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol EJSO. 2009;1:1–22.
Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, Deapen D, Salem B, Liu L, Katz SJ. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns. 2006;64(1–3):303–12.
Zdenkowski N, Butow P, Tesson S, Boyle FA. Systematic review of decision aids for patients making a decision about treatment for early breast cancer. Breast. 2016;26:31–45.
Twomey M. Autonomy and reason: treatment choice in breast cancer. Eval Clin Pract. 2012;18(5):1045–50.
Swainston K, Campbell C, van Wersch A, Durning P. Treatment decision-making in breast cancer: a longitudinal exploration of women’s experience. Lit Health Psychol. 2012;17(1):155–70.
Beauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University press; 2009.
Temple WJ, Russell ML, Parsons LL, et al. Conservation surgery for breast cancer as the preferred choice: a prospective analysis. J Clin Oncol. 2006;24:3367–73.
Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC. “Taking control of cancer”: understanding women’s choice for mastectomy. Ann Surg Oncol. 2015;22:383–91.
Molenaar S, Oort F, Sprangers M, et al. Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer. 2004;90:2123–30.
Keller J. Autonomy, relationality and feminist ethics. Hypatia. 1997;12:152–64.
Jeffrey G, et al. Understanding women’s choice of mastectomy versus breast conserving therapy in early-stage breast cancer. Clin Med Insights Oncol. 2017;11:1179554917691266. PMC. Web. 19 Aug. 2018.
McVea KL, Minier WC, Johnson Palensky JE. Low-income women with early stage breast cancer: physician and patient decision-making styles. Psychooncology. 2001;10:137–46.
Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Risky feelings: why a 6% risk of cancer does not always feel like 6%. Patient Educ Couns. 2010;81:S87–93.
Qullin JM, Lyckholm LJ. A principle-based approach to ethical issues in predictive genetic testing for breast cancer. Breast Dis. 2007;27(2006):137–48.
Lanie AD, Jayaratne JP. Exploring the public understanding of basic genetic concept. J Gene Couns. 2004;13:305–20.
McInerney J. Education in a genomic world. J Med Philos. 2002;27:369–90.
National Society of genetic counsellors. NSGC: code of ethics.
Lo B. Overview of the doctor-patient relationship. In: Resolving ethical dilemmas: a guide for clinicians. 2nd ed. Philadelphia: Lippincott Williams & Williams; 2000. p. 195.
ASHG statement, professional disclosure of familiar genetic information. the American Society of human genetics social issue subcommittee unfamiliar disclosure. Am J Hum Genet. 1998;62:474–83.
Wilson BJ, Forrest K, van Teijlingen ER, McKee L, Haites N, Matthews E, Simpson SA. Family communication about genetic risk: the little that is known. Community Genet. 2004;7:15–24.
Surbone A. Social and ethical implications of BRCA testing. Ann Oncol. 2011;22(Suppl 1):I 60–6.
Surbone A. Balance between science and mortality. Ann Oncol. 2004;15(Suppl 1):i60–4.
Jacobson N. The socially constructed breast: breast implants and the medical construction of need. Am J Public Health. 1998;88:1254–61.
Eisinger F. Prophylactic mastectomy: ethical issues. Br Med Bull. 2007;81(82):7–19.
Seneviratne S, Campbell I, Scott N, Lawrenson R. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand. BMC Health Serv Res. 2017;17:64. https://doi.org/10.1186/s12913-017-2027-4PMCID.
Raphael MJ, Biagi JJ, Kong W, Mates M, Booth CM, Mackillop WJ. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2016;160(1):17–28.
Al-Sukhun S, de Lima Lopes G Jr, Gospodarowicz M, Ginsburg O, Yu PP. Global Health Initiatives of the International Oncology Community. Am Soc Clin Oncol Educ Book. 2017;37:395–402. https://doi.org/10.14694/EDBK_100008.
Distelhorst SR, Cleary JF, Ganz PA, Bese N, Camacho-Rodriguez R, Cardoso F, Ddungu H, Gralow JR, Yip CH, Anderson BO. Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014. Breast Health Global Initiative Global Summit on Supportive Care and Quality of Life Consensus Panel Members. Lancet Oncol. 2015;16(3):e137–47.
O’Mahony M, Comber H, Fitzgerald T, Corrigan MA, Fitzgerald E, Grunfeld EA, Flynn MG, Hegarty J. Interventions for raising breast cancer awareness in women. Cochrane Database Syst Rev. 2017;2:CD011396.
Abulkhair O, Saghir N, Sedky L, Saadedin A, Elzahwary H, Siddiqui N, Al Saleh M, Geara F, Birido N, Al-Eissa N, Al Sukhun S, Abdulkareem H, Ayoub MM, Deirawan F, Fayaz S, Kandil A, Khatib S, El-Mistiri M, Salem D, Sayd el SH, Jaloudi M, Jahanzeb M, Gradishar WI. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. MENA Breast Cancer Regional Guidelines Committee. J Natl Compr Cancer Netw. 2010;8(Suppl 3):S8–S15.
Kobetz E, Mendoza AD, Barton B, Menard J, Allen G, Pierre L, Diem J, McCoy V, McCoy C. Mammography use among Haitian women in Miami, Florida: an opportunity for intervention. J Immigr Minor Health. 2010;12(3):418–21.
Parker L, Carter S, Williams J, Pickles K, Barratt A. Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices. Eur J Cancer. 2017;85:1–5. https://doi.org/10.1016/j.ejca.2017.07.056.
Parker L. Including values in evidence-based policy making for breast screening: An empirically grounded tool to assist expert decision makers. Health Policy. 2017;121(7):793–9. https://doi.org/10.1016/j.healthpol.2017.03.002.
Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51(16):2296–30.
Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer. 2015;51(12):1497–510.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Carmichael, A.R., Sandelin, K. (2019). Ethics and Breast Cancer. In: Ferreres, A. (eds) Surgical Ethics. Springer, Cham. https://doi.org/10.1007/978-3-030-05964-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-05964-4_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05963-7
Online ISBN: 978-3-030-05964-4
eBook Packages: MedicineMedicine (R0)